Interpace Diagnostics misses by $0.03, beats on revenue

Interpace Diagnostics (NASDAQ:): Q1 EPS of -$0.11 misses by $0.03.

Revenue of $4.81M (+38.6% Y/Y) beats by $0.51M.

Now read:

Leave a Reply

Your email address will not be published. Required fields are marked *

*